Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: Scientific and ethical considerations

Wendy R. Galpern, Jacqueline Corrigan-Curay, Anthony E. Lang, Jeffrey Kahn, Danilo Tagle, Roger A. Barker, Thomas B. Freeman, Christopher G. Goetz, Karl Kieburtz, Scott Y.H. Kim, Steven Piantadosi, Amy Comstock Rick, Howard J. Federoff

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)643-650
    Number of pages8
    JournalThe Lancet Neurology
    Volume11
    Issue number7
    DOIs
    StatePublished - Jul 1 2012

    ASJC Scopus subject areas

    • Clinical Neurology

    Cite this

    Galpern, W. R., Corrigan-Curay, J., Lang, A. E., Kahn, J., Tagle, D., Barker, R. A., Freeman, T. B., Goetz, C. G., Kieburtz, K., Kim, S. Y. H., Piantadosi, S., Comstock Rick, A., & Federoff, H. J. (2012). Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: Scientific and ethical considerations. The Lancet Neurology, 11(7), 643-650. https://doi.org/10.1016/S1474-4422(12)70064-9